Loggins Jamie P, Urquhart Andrew
Department of General Surgery, Marshfield Clinic, Marshfield, WI 54449, USA.
J Am Coll Surg. 2004 Jul;199(1):58-61. doi: 10.1016/j.jamcollsurg.2004.03.004.
Surgical parotidectomies place parotid lymphoma patients at increased risk of morbidity because of the diffuse infiltrative nature of the disease. These tumors usually respond to radiotherapy or chemotherapy, but are difficult to distinguish from other benign parotid gland tumors preoperatively. We sought to identify clinical and radiologic features that could aid in the preoperative distinction of parotid lymphomas.
We performed a retrospective chart review of 248 superficial parotidectomy patients.
Of 248 parotid lesions, 22 (8.8%) were lymphomas (21 non-Hodgkin's, 1 Hodgkin's). The lymphoma cases included four patients with a history of autoimmune disease, and four with a previous diagnosis of lymphoma. Palpable painless masses were present in all cases (14 right, 7 left, 1 bilateral). Two patients had multiple palpable parotid nodules and five had palpable cervical adenopathy. Of 17 patients receiving preoperative CT scans, 4 more patients were revealed to have bilateral disease, 7 more patients had cervical adenopathy, and 5 more patients had multiple parotid nodules. Tumors were poorly circumscribed in 7 of 17 (41%), and diffuse parotid changes were noted in 2. Preoperative fine needle aspiration biopsy was performed in 10 of the 22 lymphomas, revealing 3 reactive nodes, 3 suspicious for lymphoma and 3 nondiagnostic.
Although parotid lymphomas are uncommon, a history of autoimmune disease or previous lymphoma; clinical or radiologic evidence of bilateral, multiple, or poorly circumscribed parotid lesions; and cervical lymphadenopathy should suggest this diagnosis. This may alter the proposed surgery and decrease the potential morbidity associated with superficial parotidectomy in cases of parotid lymphoma.
由于腮腺淋巴瘤具有弥漫浸润性,手术切除腮腺会增加患者发病风险。这些肿瘤通常对放疗或化疗有反应,但术前很难与其他腮腺良性肿瘤区分开来。我们试图确定有助于术前鉴别腮腺淋巴瘤的临床和放射学特征。
我们对248例行腮腺浅叶切除术的患者进行了回顾性病历审查。
在248例腮腺病变中,22例(8.8%)为淋巴瘤(21例非霍奇金淋巴瘤,1例霍奇金淋巴瘤)。淋巴瘤病例包括4例有自身免疫性疾病史的患者和4例先前诊断为淋巴瘤的患者。所有病例均有可触及的无痛肿块(右侧14例,左侧7例,双侧1例)。2例患者有多个可触及的腮腺结节,5例有可触及的颈部淋巴结肿大。在17例接受术前CT扫描的患者中,又有4例被发现有双侧病变,7例有颈部淋巴结肿大,5例有多个腮腺结节。17例中有7例(41%)肿瘤边界不清,2例有弥漫性腮腺改变。22例淋巴瘤中有10例进行了术前细针穿刺活检,结果显示3例为反应性淋巴结,3例疑似淋巴瘤,3例未明确诊断。
尽管腮腺淋巴瘤并不常见,但有自身免疫性疾病史或先前淋巴瘤病史;双侧、多发或边界不清的腮腺病变的临床或放射学证据;以及颈部淋巴结肿大应提示该诊断。这可能会改变拟行的手术方式,并降低腮腺淋巴瘤患者行腮腺浅叶切除术相关的潜在发病率。